The Promise of Oncoimmunology: Integrating Immunotherapy with Conventional Cancer Treatments

@article{CheenaChawla2014ThePO,
  title={The Promise of Oncoimmunology: Integrating Immunotherapy with Conventional Cancer Treatments},
  author={P. CheenaChawla and A. Chawla},
  journal={Journal of Integrative Oncology},
  year={2014},
  volume={2014}
}
The goal of immunotherapy is to eliminate cancer cells through the transfer of ex vivo expanded and activated immune cells. Immune cells such as Dendritic Cells (DCs), Natural Killer (NK) cells, Cytotoxic T-cells, and Cytokine Induced Killer (CIK) cells have been investigated for active immunotherapy against cancer. Besides, the passive transfer of Monoclonal Antibodies has been an effective treatment for some cancers. However, for immunotherapy to become the mainstay of treating various… Expand
Review on Cancer Therapy
Types of Cancer and Surgery in Rats (Rattus norvegicus)
Elvitegravir and its Validation: A Review
Role of Immunoglobulin against Infections

References

SHOWING 1-10 OF 28 REFERENCES
Cell technologies in immunotherapy of cancer.
Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
Dendritic cells: tools and targets for antitumor vaccination
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors
Vaccination of patients with solid tumours.
Inflammation and immune surveillance in cancer.
Recent advances in therapeutic cancer vaccines.
  • J. Schlom
  • Medicine
  • Cancer biotherapy & radiopharmaceuticals
  • 2012
Third generation dendritic cell vaccines for tumor immunotherapy.
...
1
2
3
...